Vertebrobasilar Atherothrombotic Disease Treatment & Management
- Author: Eddy S Lang, MDCM, CCFP(EM), CSPQ; Chief Editor: Robert E O'Connor, MD, MPH more...
Emergency Department Care
Vertebrobasilar atherothrombotic disease (VBATD) management in the emergency department (ED) varies on the basis of the patient's symptoms and condition.
- For patients with VBATD who have experienced ischemic infarcts, management falls into 2 major categories: supportive measures and interventions to reestablish patency in the infarct-related artery or to prevent occlusion of a vessel at risk for atherothrombotic or embolic occlusion.
- Airway issues must be addressed in patients with brainstem infarction resulting from VBATD.
- Compromise of ninth and tenth cranial nerves can blunt the gag reflex and inhibit even a conscious or awake patient from handling secretions effectively.
- Secure the airway of patient with an unstable course or severe deficits before starting prolonged diagnostic imaging studies.
- Patients who present to the ED with ischemic stroke are often hypertensive, even in the absence of premorbid blood pressure elevations.
- Given the autoregulatory curve's tendency to shift to the right during hypertension, most authors caution against lowering the blood pressure in the first 24-48 hours after onset of stroke.
- A precipitous drop in blood pressure can have a significant impact on cerebral perfusion pressure.
- Consider antihypertensive medication only in cases of concomitant hypertensive emergency (ongoing end-organ damage), mean arterial pressure (MAP) greater than 130 mm Hg, or systolic blood pressure greater than 220 mm Hg.
- Because most patients with significant neurologic symptoms are denied oral intake until swallowing mechanisms are evaluated, goals of intravenous fluid therapy are to provide isotonic hydration and to avoid hyperglycemia, which appears to exacerbate neuronal injury in stroke.
- Treat vomiting with antiemetics; vomiting may be severe in some brainstem infarctions.
- If a hemorrhagic lesion has been excluded, patients with VBATD are treated with antiplatelet agents or, in certain circumstances, an anticoagulant such as warfarin (see Medication). Reperfuse the infarct-related artery by intra-arterial thrombolysis or percutaneous transluminal angioplasty (see Consultations).
See the list below:
- Neurosurgeon: Consultation with a neurosurgeon is indicated for surgical evacuation of cerebellar hemorrhages and to manage cerebellar infarction complicated by hydrocephalus.
- Interventional neuroradiologist
- Intra-arterial thrombolysis: The high mortality rate associated with basilar artery occlusion and resulting brainstem infarction has prompted research into reperfusion therapy via intra-arterial infusion of thrombolytic agents (see Medication). Several case series and small randomized controlled trials have shown promise with regards to recanalization and improved clinical outcomes in basilar artery occlusion and vertebrobasilar stroke.[6, 7] Prethrombolysis and postthrombolysis angiograms are shown below.
- Percutaneous transluminal cerebral angioplasty: Increasingly, investigators have described successful dilation of high-grade vertebral artery stenoses in patients with VBATD who did not respond to medical therapy. Although this approach is not without risk (rate of stroke as high as 40% in some series), other studies have described 80% success rates in restoring flow and eliminating symptoms.
Flossmann E, Rothwell PM. Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain. 2003 Sep. 126(Pt 9):1940-54. [Medline].
Goldmakher GV, Camargo EC, Furie KL, Singhal AB, Roccatagliata L, Halpern EF, et al. Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke. 2009 Jan. 40(1):134-9. [Medline].
Pade O, Eggers J, Schreiber SJ, Valdueza J. Complete basilar artery assessment by transcranial color-coded duplex sonography using the combined transforaminal and transtemporal approach. Ultraschall Med. 2011 Dec. 32 Suppl 2:E63-8. [Medline].
[Guideline] Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May. 38(5):1655-711. [Medline].
Coull BM, Williams LB, Goldstein LS. Anticoagulants and antiplatelet agents in acute ischemic stroke. Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association). Neurology. 2002. 59 (1):13-22. [Medline].
Brandt T, von Kummer R, Muller-Kuppers M. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke. 1996 May. 27(5):875-81. [Medline].
Webb S, Yashar P, Kan P, Siddiqui AH, Hopkins LN, Levy EI. Treatment and outcomes of acute intracranial vertebrobasilar artery occlusion: one institution's experience. J Neurosurg. 2012 Feb 3. [Medline].
Sivenius J, Riekkinen PJ, Smets P. The European Stroke Prevention Study (ESPS): results by arterial distribution. Ann Neurol. 1991 Jun. 29(6):596-600. [Medline].
International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997 May 31. 349(9065):1569-81. [Medline].
Whisnant JP, Cartlidge NE, Elveback LR. Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence--a population study. Ann Neurol. 1978 Feb. 3(2):107-15. [Medline].
Macleod MR, Davis SM, Mitchell PJ. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005. 20(1):12-7. [Medline].
Becker KJ, Purcell LL, Hacke W. Vertebrobasilar thrombosis: diagnosis, management, and the use of intra- arterial thrombolytics. Crit Care Med. 1996 Oct. 24(10):1729-42. [Medline].
Caplan LR. Vertebrobasilar occlusive disease. Stroke: Pathophysiology, Diagnosis and Management. 1992. Vol 1: 549-619.
[Guideline] Culebras A, Kase CS, Masdeu JC. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association. Stroke. 1997 Jul. 28(7):1480-97. [Medline].
Delaney KA. Bedside diagnosis of vertigo: value of the history and neurological examination. Acad Emerg Med. 2003 Dec. 10(12):1388-95. [Medline].
[Guideline] Feinberg WM, Albers GW, Barnett HJ. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Circulation. 1994 Jun. 89(6):2950-65. [Medline].
Froehling DA, Silverstein MD, Mohr DN. The rational clinical examination. Does this dizzy patient have a serious form of vertigo?. JAMA. 1994 Feb 2. 271(5):385-8. [Medline].
Libman RB, Kwiatkowski TG, Hansen MD. Differences between anterior and posterior circulation stroke in TOAST. Cerebrovasc Dis. 2001. 11(4):311-6. [Medline].
Lipinski CA, Swanson ER. Vertebrobasilar distribution stroke mimicking transtentorial herniation. Ann Emerg Med. 1998 May. 31(5):640-2. [Medline].
Ois A, Gomis M, Rodriguez-Campello A, et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke. 2008 Jun. 39(6):1717-21. [Medline]. [Full Text].
Phan TG, Wijdicks EF. Intra-arterial thrombolysis for vertebrobasilar circulation ischemia. Crit Care Clin. 1999 Oct. 15(4):719-42, vi. [Medline].
Piechowski-Jozwiak B, Bogousslavsky J. Basilar occlusive disease: the descent of the feared foe?. Arch Neurol. 2004 Apr. 61(4):471-2. [Medline].
Sauvaget E, Kici S, Petelle B. Vertebrobasilar occlusive disorders presenting as sudden sensorineural hearing loss. Laryngoscope. 2004 Feb. 114(2):327-32. [Medline].
Terada T, Higashida RT, Halbach VV. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry. 1996 Apr. 60(4):377-81. [Medline].
Voetsch B, DeWitt LD, Pessin MS. Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol. 2004 Apr. 61(4):496-504. [Medline].
Markus HS, Bart van der Worp H, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurology. 2013. 12:990. [Medline].
Kim JS, Cho KH, Lee H. Isolated labyrinthine infarction as a harbinger of anterior inferior cerebellar artery territory infarction with normal diffusion-weighted brain MRI. Journal of the Neurological Sciences. 2009. 278(1-2):82-4. [Medline].
Schneider JI, Olshaker JS. Vertigo, vertebrobasilar disease, and posterior circulation ischemic stroke. Emerg Med Clin North Am. 2012 Aug. 30(3):681-93. [Medline].
Morasch MD. Vertebral Artery Disease. Cronenwett JL and Johnston KW. Rutherford's Vascular Surgery. 8th. Toronto: Saunders; 2014. Chapter 107. [Full Text].
Khan S, Rich P, Clifton A and Markus HS. Noninvasive Detection of Vertebral Artery Stenosis: A Comparison of Contrast-Enhanced MR Angiography, CT Angiography, and Ultrasound. Stroke. 2009. 40(11):3499-3503. [Medline]. [Full Text].
Sarikaya H, Arnold M, Engelter ST, Lyrer PA, Mattle HP, Georgiadis D, et al. Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke. Stroke. 2011. 42(9):2498-502. [Medline].
Suri MF, Johnston SC. Epidemiology of intracranial stenosis. J Neuroimaging. 2009 Oct. 19 (suppl 1):11S-6S. [Medline].
Markus HS, Khan U, Birns J, Evans A, Kalra L, Rudd AG, et al. Differences in stroke subtypes between black and white patients with stroke: the South London Ethnicity and Stroke Study. Circulation. 2007 Nov 6. 116(19):2157-64. [Medline].